newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces Full Year and Fourth Quarter 2021 Financial and Business Results

●2021 Full Year Net Revenue of $41.3 Million up 28% vs Prior Year; Fourth Quarter Net Revenue of $10.9 Million up 13% vs Prior Year ●2021 Full Year Net Loss Improved $11.5 Million vs Prior Year ●Full year Cash Collections improved by 31% to $4